CIPLA.NS Balance Sheet
Cipla Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 9 years on file
(FY2017-18 to FY2025-26)
· fetched 2026-08-23 21:42
| Line item | FY2017-18 | FY2018-19 | FY2019-20 | FY2020-21 | FY2021-22 | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|---|---|---|---|---|
| Property, Plant and Equipment | N/A | N/A | N/A | N/A | N/A | ₹49.91 Bn | ₹50.69 Bn | ₹52.62 Bn | ₹60.40 Bn | PropertyPlantAndEquipment |
| Capital Work-in-Progress | N/A | N/A | N/A | N/A | N/A | ₹6.89 Bn | ₹8.64 Bn | ₹12.13 Bn | ₹15.86 Bn | CapitalWorkInProgress |
| Goodwill | N/A | N/A | N/A | N/A | N/A | ₹29.84 Bn | ₹31.12 Bn | ₹32.70 Bn | ₹37.54 Bn | Goodwill |
| Other Intangible Assets | N/A | N/A | N/A | N/A | N/A | ₹11.26 Bn | ₹13.13 Bn | ₹13.63 Bn | ₹26.40 Bn | OtherIntangibleAssets |
| Non-current Investments | N/A | N/A | N/A | N/A | N/A | ₹4.82 Bn | ₹5.12 Bn | ₹4.99 Bn | ₹4.32 Bn | NoncurrentInvestments |
| Other Non-current Assets | N/A | N/A | N/A | N/A | N/A | ₹8.06 Bn | ₹7.61 Bn | ₹9.25 Bn | ₹12.30 Bn | OtherNoncurrentAssets |
| Total Non-current Assets | N/A | N/A | N/A | N/A | N/A | ₹121.88 Bn | ₹132.76 Bn | ₹140.99 Bn | ₹183.49 Bn | NoncurrentAssets |
| Inventories | N/A | N/A | N/A | N/A | N/A | ₹51.56 Bn | ₹52.38 Bn | ₹56.42 Bn | ₹65.97 Bn | Inventories |
| Trade Receivables | N/A | N/A | N/A | N/A | N/A | ₹40.57 Bn | ₹47.71 Bn | ₹55.06 Bn | ₹56.20 Bn | TradeReceivablesCurrent |
| Cash and Cash Equivalents | N/A | N/A | N/A | N/A | N/A | ₹6.28 Bn | ₹6.40 Bn | ₹5.89 Bn | ₹10.18 Bn | CashAndCashEquivalents |
| Current Investments | N/A | N/A | N/A | N/A | N/A | ₹30.90 Bn | ₹48.07 Bn | ₹72.93 Bn | ₹76.79 Bn | CurrentInvestments |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A | ₹8.49 Bn | ₹9.00 Bn | ₹10.55 Bn | ₹14.59 Bn | OtherCurrentAssets |
| Total Current Assets | N/A | N/A | N/A | N/A | N/A | ₹168.05 Bn | ₹193.92 Bn | ₹232.49 Bn | ₹241.46 Bn | CurrentAssets |
| Total Assets | N/A | N/A | N/A | N/A | N/A | ₹294.63 Bn | ₹327.18 Bn | ₹373.87 Bn | ₹424.96 Bn | Assets |
| Equity Share Capital | N/A | N/A | N/A | N/A | N/A | ₹1.61 Bn | ₹1.61 Bn | ₹1.62 Bn | ₹1.62 Bn | EquityShareCapital |
| Other Equity | N/A | N/A | N/A | N/A | N/A | ₹232.46 Bn | ₹265.45 Bn | ₹310.32 Bn | ₹342.70 Bn | OtherEquity |
| Equity Attributable to Owners | N/A | N/A | N/A | N/A | N/A | ₹234.08 Bn | ₹267.06 Bn | ₹311.93 Bn | ₹344.32 Bn | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | N/A | N/A | N/A | N/A | N/A | ₹3.06 Bn | ₹0.96 Bn | ₹0.96 Bn | ₹0.88 Bn | NonControllingInterest |
| Total Equity | N/A | N/A | N/A | N/A | N/A | ₹237.14 Bn | ₹268.02 Bn | ₹312.89 Bn | ₹345.20 Bn | Equity |
| Long-term Borrowings | N/A | N/A | N/A | N/A | N/A | ₹0.00 Bn | ₹0.00 Bn | ₹0.12 Bn | ₹1.17 Bn | BorrowingsNoncurrent |
| Total Non-current Liabilities | N/A | N/A | N/A | N/A | N/A | ₹6.40 Bn | ₹6.70 Bn | ₹6.14 Bn | ₹9.62 Bn | NoncurrentLiabilities |
| Short-term Borrowings | N/A | N/A | N/A | N/A | N/A | ₹5.20 Bn | ₹2.47 Bn | ₹0.80 Bn | ₹1.41 Bn | BorrowingsCurrent |
| Trade Payables | N/A | N/A | N/A | N/A | N/A | ₹24.57 Bn | ₹24.74 Bn | ₹28.37 Bn | ₹32.30 Bn | TradePayablesCurrent |
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | ₹2.84 Bn | ₹3.12 Bn | ₹2.93 Bn | ₹3.00 Bn | OtherCurrentLiabilities |
| Total Current Liabilities | N/A | N/A | N/A | N/A | N/A | ₹50.33 Bn | ₹52.46 Bn | ₹54.84 Bn | ₹70.14 Bn | CurrentLiabilities |
| Total Equity and Liabilities | N/A | N/A | N/A | N/A | N/A | ₹294.63 Bn | ₹327.18 Bn | ₹373.87 Bn | ₹424.96 Bn | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from CIPLA.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).